Kiniksa Pharmaceuticals International, plc Operating Lease, Liability, Noncurrent
Kiniksa Pharmaceuticals International, plc (KNSA) had Operating Lease, Liability, Noncurrent of $5.86 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-04-28
- 2026-03-31: Operating Lease, Liability, Noncurrent $5.86M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $6.51M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $7.02M.
- 2025-06-30: Operating Lease, Liability, Noncurrent $7.24M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-03-31 | $5.86M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $6.51M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $7.02M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $7.24M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $7.62M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $7.86M 10-K · filed 2026-02-24 |
| 2024-09-30 | $8.56M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $9.32M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $9.86M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $10.01M 10-K · filed 2025-02-25 |
| 2023-09-30 | $10.65M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $11.28M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $2.13M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.62M 10-K · filed 2024-02-28 |
| 2022-09-30 | $3.44M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.28M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.10M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.67M 10-K · filed 2023-03-02 |
| 2021-09-30 | $3.50M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.50M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.20M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.88M 10-K · filed 2022-02-24 |
| 2020-09-30 | $55.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $139.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $551.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $955.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.39M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.82M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.24M 10-Q · filed 2019-05-07 |